Dusseldorf - Delayed Quote EUR

Brainstorm Cell Therapeutics Inc (GHDN.DU)

0.4555 +0.0070 (+1.56%)
As of 8:11 AM GMT+2. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Expense
21,550.0000
24,822.0000
24,539.0000
31,684.0000
Operating Income
-21,550.0000
-24,822.0000
-24,539.0000
-31,684.0000
Net Non Operating Interest Income Expense
-12.0000
545.0000
82.0000
-127.0000
Pretax Income
-16,632.0000
-24,277.0000
-24,457.0000
-31,811.0000
Net Income Common Stockholders
-16,632.0000
-24,277.0000
-24,457.0000
-31,811.0000
Diluted NI Available to Com Stockholders
-16,632.0000
-24,277.0000
-24,457.0000
-31,811.0000
Basic EPS
-0.42
-0.66
-0.68
-1.07
Diluted EPS
-0.42
-0.66
-0.68
-1.07
Basic Average Shares
39,346.4080
36,509.0600
36,181.7530
29,848.2170
Diluted Average Shares
39,346.4080
36,509.0600
36,181.7530
29,848.2170
Total Operating Income as Reported
-21,550.0000
-24,822.0000
-24,539.0000
-31,684.0000
Total Expenses
21,550.0000
24,822.0000
24,539.0000
31,684.0000
Net Income from Continuing & Discontinued Operation
-16,632.0000
-24,277.0000
-24,457.0000
-31,811.0000
Normalized Income
-21,562.0000
-24,277.0000
-24,457.0000
-31,811.0000
Interest Income
--
545.0000
82.0000
--
Net Interest Income
-12.0000
545.0000
82.0000
-127.0000
EBIT
-21,550.0000
-24,822.0000
-24,539.0000
-31,684.0000
EBITDA
-21,281.0000
-24,537.0000
-24,279.0000
-31,465.0000
Reconciled Depreciation
269.0000
285.0000
260.0000
219.0000
Net Income from Continuing Operation Net Minority Interest
-16,632.0000
-24,277.0000
-24,457.0000
-31,811.0000
Total Unusual Items Excluding Goodwill
4,930.0000
--
--
--
Total Unusual Items
4,930.0000
--
--
--
Normalized EBITDA
-26,211.0000
-24,537.0000
-24,279.0000
-31,465.0000
12/31/2020 - 3/5/2020
Yahoo Finance Plus Essential access required. Unlock Access

Related Tickers

IBPB.F Bio-Path Holdings, Inc.
0.3280
0.00%
 
APH0.F Ampio Pharmaceuticals, Inc.
0.1810
0.00%
 
CNB1.F Fortress Biotech, Inc.
4.1310
0.00%
 
HXB2.DU AIM ImmunoTech Inc
0.4400
+13.99%
 
YBO.F
 
X700.F
 
IQT0.MU Inhibikase Therapeutics Inc
2.0200
-1.94%
 
BX2.DU BioXcel Therapeutics Inc
2.3500
-3.73%
 
AKBLF ALK-Abelló A/S
18.65
0.00%
 
BIOAF Bioasis Technologies Inc.
0.0060
0.00%